期刊文献+

Fas和Fas配体在角膜移植免疫排斥反应中的表达

THE EXPRESSION OF Fas AND Fas LIGAND IN PENETRATING KERATOPLASTY REJECTION
下载PDF
导出
摘要 目的 了解Fas和Fas配体 (FasL)在发生免疫排斥的角膜植片中的表达情况 ,探讨其在角膜移植免疫排斥反应中的作用。 方法 角膜移植术后排斥反应的患者 4 2例 ,于再次行穿通性角膜移植术时取其排斥的移植片 ;正常角膜 6例。进行免疫组织化学染色 ,观察正常角膜和移植片中上皮、基质和内皮层的Fas及Fas配体的表达。 结果 在 6例正常角膜中 ,角膜上皮、内皮Fas和FasL为阳性表达。 4 2例移植片中 ,角膜上皮Fas和FasL均有表达。有新生血管形成及免疫细胞浸润的角膜基质中 ,血管内皮细胞、基质细胞FasL为阳性表达 ,Fas在部分浸润的免疫细胞中有表达 ;移植片内皮细胞层广泛破坏。 结论 Fas、FasL在角膜移植片中的表达 。 Objective To investigate the expression of Fas and Fas ligand (FasL) on the corneal graft, and evaluate its effect in penetrating keratoplasty rejection. Methods Using the monoclonal antibody of Fas and FasL, Fas and FasL expressions were assessed by immunohistochemistry in 42 cases of rejected corneal grafts and 6 cases normal corneas. Results Fas and FasL expressions were present on the normal corneal epithelium and endothelium, and epithelium of rejected corneal graft. In penetrating keratoplasty rejection, FasL was expressed in the endothelium of new vessels and stroma of cornea, and Fas was expressed in infiltrated immunocytes, and endothelium was widely damaged.Conclusion\ Fas and FasL expression on the corneal graft may be related with penetrating keratoplasty rejection.\;[
出处 《解剖学报》 CAS CSCD 北大核心 2003年第4期426-429,共4页 Acta Anatomica Sinica
基金 北京市科干局青年骨干基金 ( 2 0 0 0 0 2 )
关键词 角膜移植 移植物排斥 FAS FAS配体 Penetrating keratoplasty Rejection Fas Fasl
  • 相关文献

参考文献9

  • 1Bellgrau D, Gold D, Salawry H, et al. A role for CD95 ligand in preventing graft rejection[J].Nature,1995,377(6550):630-632.
  • 2Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege[J].Science,1995,270(5239):1189-1192.
  • 3李志杰,彭广华,李辰.细胞凋亡与眼的免疫赦免[J].眼科研究,2000,18(2):182-184. 被引量:2
  • 4Stuart PM, Griffith TS, Usui N, et al.CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survivgal[J].J Clin Invest,1997,99(3):396-402.
  • 5钟一声,程枫,王康孙.兔角膜Fas和Fas配体mRNA的表达和意义[J].眼科研究,2000,18(4):289-291. 被引量:2
  • 6Griffith TS, Yu X,Herndon JM, et al. CD95-induced apotosis of lymphocytes in an immune privileged site induces immunological tolerance[J].Immunity,1996,5(1):7-16.
  • 7王旭,谢立信.Fas和FasL介导的凋亡在角膜移植中的作用[J].国外医学(眼科学分册),1999,23(6):326-329. 被引量:4
  • 8Yamagami S, Kawashima H, Tsuru T, et al.Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants [J].Transplantation,1997,64(8):1107-1111.
  • 9Dana MR, Streilein JW. Loss and Restoration of Immune Privilege in Eyes With Corneal Neovasculatrization [J].Invest Ophthalmol Vis Sci,1996,37(12):2485-2494.

二级参考文献12

  • 1李志杰,李辰.雷公藤多甙防治角膜移植免疫排斥反应的实验研究[J].眼科研究,1996,14(2):76-78. 被引量:22
  • 2卫立辛.-[J].国外医学:分子生物学分册,1996,18(3):97-97.
  • 33.BellgrauD,GoldD,SalawryH,etal.AroleforCD95ligandinpreventinggraftrejection.Nature,1995,377∶630
  • 44.GriffithTs,BrunnerT,FletcherSM,eral.Fasligand-inducedapoptosisasamechanismofimmuneprivilege.Science,1995,270∶1189
  • 55.Nagata,S,GolsteinP.TheFasdeathfactorScience,1995,267∶1449
  • 66.StuartPM,GriffithTS,UsuiN,etal.CD95ligand(FasL)-inducedapoptosisisnecessaryforcornealallograftsurvivgal.JClinInvest,1997,99∶396
  • 79.GriffithTS,YuX,HerndonJM,etal.CD95-inducedapoptosisoflymphocytesinanimmuneprivilegedsiteinducesimmunologicaltolerance.Immunity,1996,5∶7
  • 810.LauHT,YuM,FontanaA,etal.PreventionofisletallograftrejectionwithengineeredmyoblastsexpressingFasLinmice.Science,1996,273∶109 收稿:1999-05-18修回:2000-03-29 (本文编辑:胡纯钢)
  • 91.BradySE,RapuanoJC,ArentsenJJ,etal.Clinicalindicationsandproceduresassociatedwithpenetratingkeratoplasty.AmJOphthalmol,1989,108∶118
  • 102.CouncilOnScientificAffairs.Reportoftheorgantransplantpanel:cornealtransplantation.JAmMedAssoc,1988,259∶719

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部